See Me and Not Just the Disease! An In-Depth Clinical Focus on Racial Disparities in HCV Care Globally

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis

Sherry Tierney Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 17, 2022 Expired: May 16, 2023

Clinical Care Options (CCO) commentary from Oluwaseun Falade-Nwulia, MBBS, MPH, on the need for integrating HCV services into addiction medicine settings

Oluwaseun Falade-Nwulia, MBBS, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 30, 2022 Expired: March 29, 2023

Download key slides describing lessons learned in delivery of care from the COVID-19 pandemic worth carrying forward in the management of viral hepatitis.

Gregory Dore, MBBS, PhD, FRACP, MPH Jordan J. Feld, MD, MPH Graham R. Foster, FRCP, PhD Robert G. Gish, MD Paul Y. Kwo, MD Pietro Lampertico, MD, PhD Nancy Reau, MD Norah Terrault, MD, MPH Stacey Trooskin, MD, PhD, MPH Grace LH Wong, MD Released: March 16, 2022

Dr Milosz Parczewski, discusses the latest data on LA PrEP, HCV treatment in PWH, and treatments for MDR TB presented at CROI 2022 and their relevance to the CEE, from Clinical Care Options (CCO).

Milosz Parczewski, MD, PhD Released: March 11, 2022